alexa A Novel Approach to the Treatment of Sebaceous Hyperpla
ISSN: 2155-9554

Journal of Clinical & Experimental Dermatology Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

A Novel Approach to the Treatment of Sebaceous Hyperplasia and Post- Procedural Purpura with Pulsed-Dye Laser

Paul M Graham1* and Stephen W Eubanks2

1Dermatology Resident PGY-3, St. Joseph Mercy Hospital, Ann Arbor, USA

2Dermatology and Laser Center at Harvard Park, Denver, Colorado, USA

*Corresponding Author:
Paul M. Graham
Department of Dermatology
5333 McAuley Dr # 5011
Ypsilanti, MI 48197
Michigan, USA
Tel: 757-630-9803
E-mail: [email protected]

Received date: 21 June, 2016; Accepted date: 12 July, 2016; Published date: 18 July, 2016

Citation: Graham PM, Eubanks SW (2016) A Novel Approach to the Treatment of Sebaceous Hyperplasia and Post-Procedural Purpura with Pulsed-Dye Laser. J Clin Exp Dermatol Res 7:363. doi:10.4172/2155-9554.1000363

Copyright: © 2016 Graham PM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Background: Sebaceous hyperplasia is a benign but clinically and cosmetically unappealing lesion. Historical treatments include cauterization, cryotherapy, chemical ablation, and surgical removal, all of which increase the risk for permanent post-operative adverse effects. The pulsed-dye laser (PDL) offers a safe and effective approach to the treatment of sebaceous hyperplasia in Fitzpatrick skin types I-III, but purpura was an unacceptable trade off of this treatment. We describe a subsequent follow-up treatment aimed at reducing the resulting post-PDL purpura.

Methods: Our report presents 5 patients (Fitzpatrick II-III) treated with PDL (595 nm, 5 mm spot, 20 J/cm2, 3 ms) for sebaceous hyperplasia with subsequent follow-up treatment, 24-hours later, with the same PDL (595 nm, 7 mm spot, 9 J/cm2, 6 ms, DCD 30/20) aimed at improving the post-operative purpura.

Results: Sebaceous hyperplasia and resulting purpura improved after a single combination treatment session with both high and moderate-fluence PDL. Purpura is required for effective treatment of sebaceous hyperplasia, but is subsequently treated with moderate-fluence PDL 24-hours later, offering complete resolution of post-PDL purpura within 72 hours.

Conclusion: Treatment of sebaceous hyperplasia with PDL offers a safe and effective treatment modality aimed at the underlying vasculature associated with the sebaceous gland. The high-fluence and short pulse duration required to remove the sebaceous hyperplasia often leads to the development of purpura. This post-PDL purpura is successfully treated with moderate-fluence PDL with resolution within 72 hours. In the future, we believe that many other conditions requiring high-fluence PDL that leads to purpura may also be treated with a subsequent lower dose treatment to remove any laser induced purpura.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version